113,63 €
0,58 % heute
L&S, 9. Februar, 13:54 Uhr
ISIN
US89377M1099
Symbol
TMDX
Berichte

TransMedics Group, Inc. Aktie News

Positiv
Seeking Alpha
6 Tage alt
TransMedics: Italian NOP Program Reinforces Huge International Opportunity
Positiv
Market Watch
25 Tage alt
The companies are projected to grow sales rapidly through 2027, and many of the stocks are expected to show double-digit increases this year.
Positiv
Seeking Alpha
27 Tage alt
I see a clear path for TransMedics to deliver at least mid-20% revenue growth in 2026, with upside as year-over-year comparisons get easier. I believe operating margins will continue to expand as scale improves and the bulk of U.S. infrastructure spending moves into the rearview mirror. I expect operating profits to grow faster than revenue, setting up improving free cash flow as 2026 progresses.
Neutral
Seeking Alpha
27 Tage alt
TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
PRNewsWire
28 Tage alt
ANDOVER, Mass., Jan. 12, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville, as well as the acquisition of the adjacent land parcel to create an integrated TransMedics campus environment.
Neutral
PRNewsWire
etwa ein Monat alt
ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44th Annual J.P.
Positiv
The Motley Fool
etwa ein Monat alt
These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery.
Neutral
PRNewsWire
etwa 2 Monate alt
ANDOVER, Mass. , Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 22, 2025, TransMedics granted non-qualified stock options to purchase an aggregate of 6,333 shares of its common stock and an ...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen